Yushu Technology announces it will submit an IPO application in the fourth quarter.
On September 2nd, Yushu Technology posted on social media platforms that it is expected to submit an IPO application to the securities exchange from October to December.
On September 2nd, Yushu Technology posted on social media platforms that they are expected to submit an IPO application to the stock exchange from October to December, and the company's related operational data will be officially disclosed at that time. Yushu Technology stated that in 2024, the sales of Quadruped Siasun Robot&Automation, Humanoid Siasun Robot&Automation, and component products account for approximately 65%, 30%, and 5% respectively. Of these, about 80% of Quadruped Siasun Robot&Automation are used in research, education, and consumer fields, while the remaining 20% are used in industrial fields, such as inspection and firefighting. Humanoid Siasun Robot&Automation is completely used in research, education, and consumer fields.
Since its founding, Yushu Technology has been committed to applying high-performance general-purpose Siasun Robot&Automation to various industries in civil fields, and has clearly stated and restricted this in the company's official website, product manuals, partner agreements, and various other documents.
According to the website of the China Securities Regulatory Commission on July 18th, Yushu Technology has completed counseling registration with the Zhejiang Securities Regulatory Bureau, and disclosed the counseling registration report for the initial public offering of shares and listing, with CITIC SEC as the sponsor securities company. The counseling registration report shows that Yushu Technology was established on August 26, 2016, with a registered capital of 3.64 billion yuan, and the legal representative is Wang Xingxing.
Related Articles

Maintain the "buy" rating of GCL TECH (03800) and are optimistic about the significant improvement in the company's 25H2 performance.

FIRST SHANGHAI: Maintain a "Buy" rating on SHENZHOU INTL (02313) with a target price of HK$79.80.

HK Stock Market Move | DINGDANG HEALTH (09886) rose more than 5%, the company increased its investment in the weight loss market layout and advanced cooperation with original research pharmaceutical companies.
Maintain the "buy" rating of GCL TECH (03800) and are optimistic about the significant improvement in the company's 25H2 performance.

FIRST SHANGHAI: Maintain a "Buy" rating on SHENZHOU INTL (02313) with a target price of HK$79.80.

HK Stock Market Move | DINGDANG HEALTH (09886) rose more than 5%, the company increased its investment in the weight loss market layout and advanced cooperation with original research pharmaceutical companies.

RECOMMEND

Hong Kong Stock Concept Tracker|Oracle (ORCL.US) RPO Surge Ignites AI Computing Power Chain—Domestic Opportunities in Focus
11/09/2025

Southbound Capital Flows Shift: Profit-Taking on High-Flying Stocks and Accumulating Alibaba and Tence
11/09/2025

Anti-Involution Policies Deliver Results as August Price Indicators Improve
11/09/2025